Advancing
Innovation

in Mental Health

Broaden Study bridges the gap between clinical research and life-changing neuromodulation therapies for treatment-resistant depression.
Discover Our Research

Driven by the urgent need for innovation in treatment-resistant depression.

Broaden Study serves as the bridge between pioneering research institutions and individuals seeking next-generation neurological interventions.
Educational resources on implantable stimulation technologies and mood regulation.
Deep brain stimulation research focused on chronic, debilitating mental health conditions.
Awareness of ongoing clinical trials and safety considerations for advanced therapies.
“Broaden Study is broadening the conversation around neuropsychiatric care, making complex clinical research accessible to those who need it most.”
Dr. Aris S.
Clinical Research Lead
Clinical Impact
Dedicated to advancing the understanding of treatment-resistant depression through responsible research into neuromodulation and implantable stimulation technologies.
30%
of patients typically do not respond to conventional depression treatments
100+
Active clinical trials exploring deep brain stimulation and targeted neurological therapies
*Broaden Study provides information for educational and research purposes; please consult with a medical professional regarding individual treatment pathways.

Research Pathways

Clinical Trials
We raise awareness of ongoing clinical trials and investigational pathways, helping individuals understand the process of participating in advanced neurological research.
Neuromodulation Education
We provide comprehensive resources on device-based therapies like Deep Brain Stimulation, explaining how these technologies regulate targeted areas of the brain to improve mood.
Responsible Advancement
We act as a bridge between clinicians and individuals, supporting the research-driven advancement of psychiatric care while maintaining a strict focus on safety and clinical ethics.

// Clinical Research Referenced By

Research Impact
“Broaden Study is bridging the critical gap between complex neurological research and the individuals who need these innovative therapies most.”
Dr. Steven Cooper
Lead Clinical Researcher

Clinical Excellence

We are committed to broadening the awareness of innovative mental health treatments and supporting research-driven advancement in neuropsychiatric care.
3.8M+
Individuals globally affected by treatment-resistant depression in need of new options
15+
Years of emerging research supporting neuromodulation as a viable psychiatric intervention
*Broaden Study operates as an educational and clinical awareness platform and does not provide direct medical diagnoses.

Research & Insights

Research Update
October 12, 2025
Exploring Deep Brain Stimulation: A new frontier for treatment-resistant depression
Clinical Trial
January 14, 2026
Broaden Study announces new awareness initiative for upcoming neuromodulation trials
Industry Insight
March 05, 2026
Understanding the "Brain Pacemaker": How implantable tech regulates mood

Join Our SMS List

Sign up for SMS updates to receive immediate notifications regarding new trial openings, research breakthroughs, and eligibility window alerts. Be the first to know when advanced neuromodulation studies launch in your region.
Thank you for joining the alerts list!
Try re-entering your phone number.
Email
support@broadenstudy.com
Phone
(888) 574-9174
Pages
HomeAboutEligibility ScreenerResearch ProcessParticipant PathwaysResearchNeural Circuit Explorer
Company
Terms of ServicePrivacy PolicyContact Us
© Broaden Study All Rights Reserved
Broaden Study is a clinical research and mental health innovation platform. The information provided on this website is for educational and research awareness purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Deep brain stimulation (DBS) is an investigational or specialized therapy that carries specific risks and safety considerations which should be discussed thoroughly with a clinical professional.